Literature DB >> 34138419

MiR-93 inhibits the vascular calcification of chronic renal failure by suppression of Wnt/β-catenin pathway.

Jun Peng1, Chao Qin2, Shu-Yan Tian1, Jia-Qing Peng3.   

Abstract

OBJECTIVE: To explore the effect of miR-93-mediated Wnt/β-catenin pathway on the vascular calcification (VC) of chronic renal failure (CRF).
METHODS: SD rats were utilized to construct CRF models and divided into Control, CRF, CRF + LV (lentiviral vector)-miR-93 and CRF + LV-Con groups. Renal tissues collected from rats were performed hematoxylin and eosin (HE) staining and Masson staining, while the abdominal aorta was dissected for alizarin red staining and Von Kossa staining. VC-related genes were determined by qRT-PCR while Wnt/β-catenin pathway-related proteins were examined by Western blotting.
RESULTS: As compared to Control group, the serum levels of blood urea nitrogen (BUN), serum creatinine (Scr), phosphorus (P), cystatin C (Cys-C) and 24-h urea protein (24 h Upro), and the scores of renal interstitial lesion and fibrotic area in rats from CRF group were elevated, with the increased calcified area of aorta as well as the enhanced calcium content and ALP. Meanwhile, rats in the CRF group had up-regulated expression of OPN, OCN, RUNX2 and BMP-2 and down-regulated expression of miR-93. As for the expression of Wnt/β-catenin pathway, rats in the CRF group had sharp increases in the protein expression of TCF4 and β-catenin, while α-SMA was down-regulated. However, changes of the above were reversed in rats from CRF + LV-miR-93 group, and TCF4 was confirmed to be a target gene of miR-93.
CONCLUSION: MiR-93, via inhibiting the activity of Wnt/β-catenin pathway by targeting TCF4, can improve the renal function of CRF rats, thereby mitigating the vascular calcification of CRF.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Chronic renal failure; TCF4; Vascular calcification; Wnt/β-catenin pathway; miR-93

Mesh:

Substances:

Year:  2021        PMID: 34138419     DOI: 10.1007/s11255-021-02907-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  43 in total

Review 1.  Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.

Authors:  Efstathia K Kapsogeorgou; Vasiliki C Gourzi; Menelaos N Manoussakis; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

2.  How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?

Authors:  Antonio Bellasi; Laura Kooienga; Geoffrey A Block; Emir Veledar; David M Spiegel; Paolo Raggi
Journal:  J Nephrol       Date:  2009 Mar-Apr       Impact factor: 3.902

3.  Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model.

Authors:  Odongua Sangidorj; Seung Hee Yang; Hye Ryoun Jang; Jung Pyo Lee; Ran-hui Cha; Sun Moon Kim; Chun Soo Lim; Yon Su Kim
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-19

4.  WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.

Authors:  Ting Cai; Danqin Sun; Ying Duan; Ping Wen; Chunsun Dai; Junwei Yang; Weichun He
Journal:  Exp Cell Res       Date:  2016-06-16       Impact factor: 3.905

Review 5.  [Chronic Kidney Disease].

Authors:  Christoph Wanner; Markus Ketteler
Journal:  Dtsch Med Wochenschr       Date:  2017-02-10       Impact factor: 0.628

Review 6.  Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?

Authors:  Sophie Liabeuf; Hirokazu Okazaki; Lucie Desjardins; Danilo Fliser; David Goldsmith; Adrian Covic; Andrzej Wiecek; Alberto Ortiz; Alberto Martinez-Castelao; Bengt Lindholm; Gultekin Suleymanlar; Francesca Mallamaci; Carmine Zoccali; Gerard London; Ziad A Massy
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

Review 7.  Stem cell technology for the treatment of acute and chronic renal failure.

Authors:  Christopher J Pino; H David Humes
Journal:  Transl Res       Date:  2010-07-30       Impact factor: 7.012

Review 8.  Adult chronic kidney disease: neurocognition in chronic renal failure.

Authors:  Nikhil S Koushik; Steven F McArthur; Anne D Baird
Journal:  Neuropsychol Rev       Date:  2009-08-25       Impact factor: 7.444

9.  Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.

Authors:  Hui-Teng Cheng; Jenq-Wen Huang; Chih-Kang Chiang; Chung-Jen Yen; Kuan-Yu Hung; Kwan-Dun Wu
Journal:  J Clin Endocrinol Metab       Date:  2012-02-15       Impact factor: 5.958

10.  Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.

Authors:  Campbell R Sheen; Pia Kuss; Sonoko Narisawa; Manisha C Yadav; Jessica Nigro; Wei Wang; T Nicole Chhea; Eduard A Sergienko; Kapil Kapoor; Michael R Jackson; Marc F Hoylaerts; Anthony B Pinkerton; W Charles O'Neill; José Luis Millán
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

View more
  1 in total

Review 1.  Extracellular vesicles in vascular remodeling.

Authors:  Chao Ye; Fen Zheng; Nan Wu; Guo-Qing Zhu; Xiu-Zhen Li
Journal:  Acta Pharmacol Sin       Date:  2022-01-12       Impact factor: 7.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.